Capital B Raises €21 Million to Buy Bitcoin: The Dilution That Nobody Is Calculating

While others see another European company stacking sats, the plumbing shows a warrant structure that could strip 24.1% of shareholder Bitcoin exposure. I have audited smart contracts that were less dangerous than this capital table. Capital B, a European Bitcoin Treasury Company, just announced a €21 million private placement. The headline is simple: buy 270 more Bitcoin, grow the treasury from 3,145 BTC to 3,415 BTC. But beneath this straightforward narrative lies a complex web of warrants, pre-authorized capital, and diluted per-share metrics that most investors will never calculate. This is not a technology story. It is a capital structure story, and the capital structure has a ticking time bomb inside it. Let me be precise about what Capital B actually is. It is not a blockchain protocol. It is not building infrastructure. It is a publicly listed company that uses its balance sheet to hold Bitcoin, effectively offering shareholders indirect exposure to the asset. MicroStrategy pioneered this model. Michael Saylor's company turned a failing software business into a leveraged Bitcoin vehicle, and the market rewarded him with a valuation premium that at times reached two to three times the value of the underlying BTC holdings. Capital B is a follower in this playbook, operating out of Europe with a much smaller footprint. Code is law, but incentives are god. In this case, the incentive structure embedded in the warrant terms tells me everything I need to know about what happens next. The mechanics of this raise deserve scrutiny. Capital B is issuing 36,219,070 new shares at €0.58 per unit. Each unit comes with four warrants attached. Four. These warrants carry exercise prices of €0.75, €0.98, and €1.27, with a five-year maturity. If all warrants are exercised, they represent a further 144,876,280 shares of potential dilution. That is roughly four times the number of shares being issued in the immediate placement. Now let me walk you through what this actually means for existing shareholders. I have spent years analyzing capital structures, first in traditional markets and then in crypto. The key metric for any Bitcoin Treasury Company is not the total BTC held. It is the BTC per share, or more practically, BTC per million shares. Before this raise, Capital B held approximately 7.4725 BTC per million shares. After the immediate placement, that number drops marginally to 7.4711 BTC per million shares. A negligible change of negative 0.02 percent. The company can honestly claim the spot transaction is roughly neutral to shareholder Bitcoin exposure. But here is the part they are not putting in the press release. If all warrants are exercised, the per-million-share BTC figure falls to 5.6730. That is a 24.1 percent reduction in Bitcoin exposure per share. Let that number sink in. A quarter of your Bitcoin exposure evaporates if the company successfully executes the full warrant program. The warrants are priced at a premium to the current placement price, which means they only get exercised if the stock rises significantly. If the stock does not rise, the warrants expire worthless and the company does not get the additional capital. If the stock does rise, existing shareholders get diluted by 24.1 percent. This is what I call a heads-I-win-tails-you-lose structure, except the "you" is the existing shareholder. I have seen this pattern before. In 2017, I audited ICO projects with token vesting schedules that looked reasonable on the surface but contained hidden advisor allocations and foundation reserves that could dump at any moment. The same structural opacity exists here. The company's own disclosure admits that its dilution calculations exclude older BSA-series warrants, convertible bond warrants, and an unissued €300 million TOBAM facility. This is a red flag that deserves serious attention. I have reviewed enough capital structures to know that when a company excludes certain instruments from its dilution math, it is usually because including them would make the numbers look significantly worse. The disclosed 24.1 percent potential dilution is likely the floor, not the ceiling. Let me add some context from my own experience. In 2020, I managed a cross-protocol liquidity strategy across Compound, Uniswap, and Aave. I was earning 40 percent annualized returns by reallocating $500,000 every 48 hours to exploit interest rate discrepancies. It felt like genius until I realized I was participating in a debt ponzi. The yields were not coming from real economic activity. They were coming from new liquidity entering the system. When I look at Capital B's model, I see the same dynamic. The company raises equity, buys Bitcoin, and hopes the Bitcoin appreciation outpaces the dilution cost. In a bull market, this works beautifully. In a bear market, it becomes a death spiral: falling stock price makes further raises more dilutive, which further depresses the stock price, which makes the next raise even more painful. Based on my audit experience, I have learned to look at what happens under stress, not what happens in the happy path. The happy path for Capital B is Bitcoin continues to rise, the stock price appreciates, warrants get exercised, and the company uses the proceeds to buy more Bitcoin, maintaining or slightly increasing per-share BTC exposure. The stress path is Bitcoin goes sideways or declines. Then the warrants stay unexercised, the company cannot raise additional capital without even more severe dilution, and the per-share BTC metric stagnates or declines. Meanwhile, the company still has to pay operating expenses, which means selling Bitcoin or issuing more shares at unfavorable prices. The valuation question is equally troubling. Capital B's market position is marginal. With 3,145 BTC in the treasury, it holds roughly 1.4 percent of MicroStrategy's 226,500 BTC. Metaplanet in Japan holds over 500 BTC. Boyaa Interactive, a Hong Kong-listed gaming company, holds over 2,000 BTC. Capital B is a small player in a niche market, and it lacks the brand recognition, liquidity, and institutional trust of the sector leader. Its European market positioning is a differentiator, but it is also a limitation. European institutional investors have historically been more conservative about crypto exposure than their US counterparts. I want to dig deeper into the governance question, because this is where the real risk lies. In June, shareholders authorized a €5 billion capital increase and a €100 billion credit facility. Let me put that in perspective. The company is raising €21 million now, but management has authorization to raise €5 billion. That is a 238-fold difference. The credit facility authorization is even more extreme. Management has enormous latitude to dilute shareholders, and the warrant structure suggests they intend to use it. This is not necessarily malicious. It may be strategic. But from a shareholder perspective, it is a massive overhang. Every future raise will dilute existing holders. The company's entire model depends on Bitcoin's appreciation outpacing the dilution cost. In a bull market, that math can work. But the margin of safety is thin, and the information asymmetry is significant. Bubbles don't burst when everyone knows they are bubbles. They burst when the marginal buyer realizes the fundamental story has changed. For Capital B, that moment comes when investors start calculating the fully diluted BTC per share and realize they are getting significantly less Bitcoin exposure than the headline suggests. Let me compare this to MicroStrategy's approach. Saylor used convertible notes, which are debt instruments that convert into equity at a future date. Until conversion, they do not dilute existing shareholders. The conversion price is typically set at a premium to the current stock price, meaning shareholders get some protection. Capital B's warrant structure is more aggressive. Warrants are attached to the placement units themselves, creating immediate contingent dilution. The exercise prices are set at various levels, but the overall structure is more shareholder-hostile than the convertible note model. Why would a company choose warrants over convertibles? Several possibilities. European market conditions may favor warrants for smaller issuers. Regulatory requirements may differ. Or the company may have found that warrants are easier to market to investors who want a free option on the stock price. Whatever the reason, the result is a structure that treats existing shareholders as a source of capital rather than as partners in the enterprise. I have seen this movie before. In 2022, I watched Terra collapse not because the algorithmic stablecoin had a technical flaw, but because the entire ecosystem was built on leverage that required continuous new inflows. The moment inflows stopped, the whole thing unwound. Capital B is not Terra. It holds real Bitcoin, and Bitcoin is a genuinely scarce asset with a proven track record. But the financing structure has similar characteristics: it requires continuous appreciation to remain viable. The market context matters here. We are in a bull market. Bitcoin has appreciated significantly, and the narrative around Bitcoin Treasury Companies is still gaining traction. MicroStrategy's success has attracted imitators, and Capital B is part of that wave. But bull markets mask structural flaws. The same way ICOs looked brilliant in 2017 until the music stopped, Bitcoin Treasury Companies look brilliant now until Bitcoin enters a prolonged bear market. Let me be clear about what I am not saying. I am not saying Capital B is a fraud. I am not saying the company is doomed. I am saying the risk-reward profile is significantly worse than the narrative suggests, and that the dilution risk is being systematically underestimated by retail investors who see "company buys Bitcoin" and stop their analysis there. I have been in this industry long enough to know that the most dangerous investments are not the ones that look risky. They are the ones that look safe. A European listed company buying Bitcoin sounds prudent. It sounds like institutional adoption. It sounds like the mature end of the crypto market. But the capital structure tells a different story. The warrants, the authorized capital, the undisclosed dilution instruments, and the reliance on Bitcoin's continuous appreciation create a risk profile that is anything but safe. For the contrarian angle, let me question the metric itself. The industry has adopted "BTC per share" as the key performance indicator for Bitcoin Treasury Companies. But is this the right metric? If a company holds Bitcoin and the price of Bitcoin rises, shareholders benefit regardless of the per-share metric, as long as the total holdings increase. The per-share metric only matters if you believe the stock price will track it. In practice, the stock price is driven by narrative, sentiment, and liquidity, not just by the underlying BTC holdings. MicroStrategy's stock has traded at significant premiums and discounts to its NAV, suggesting that the market prices in factors beyond just the Bitcoin holdings. But the per-share metric still matters for one critical reason: it is the anchor that keeps the narrative honest. If Capital B's stock trades at a premium to its NAV, investors need to justify that premium. If the per-share BTC metric is declining, the premium becomes harder to justify. The warrant structure creates a situation where the per-share metric will decline if the warrants are exercised, which means the stock price needs to rise significantly just to keep the premium reasonable. This is a fragile setup. I want to also address the timing. This raise is happening in late August 2025, with settlement scheduled for August 31. Bitcoin is trading at historically high levels, and the market is showing signs of local overheating. Raising capital at these levels is smart if you believe Bitcoin will continue to rise. It is dangerous if you believe a correction is imminent. The company is essentially buying Bitcoin at current prices with newly issued equity. If Bitcoin corrects 20 percent, the company's treasury value drops by 20 percent, but the new shares are already issued and the warrants are outstanding. The dilution is locked in regardless of subsequent price action. There is also a regulatory dimension that deserves attention. The European Union's MiCA regulation is being implemented, and its impact on how listed companies disclose crypto holdings is still unclear. If regulators start requiring more detailed disclosure of dilution instruments, companies like Capital B may come under increased scrutiny. This could limit their ability to execute the aggressive financing strategies they have been authorized to pursue. Let me return to the governance issue, because it is central to the risk assessment. Shareholders authorized €5 billion in capital increases and €100 billion in credit facilities. This is an extraordinary level of trust. Management now has the ability to dilute shareholders at will, subject only to board approval and regulatory constraints. The warrant structure suggests they intend to use this authority aggressively. Whether this is in shareholders' long-term interest depends entirely on Bitcoin's price trajectory. If Bitcoin doubles from here, the dilution may be more than compensated by the increased treasury value. If Bitcoin goes sideways, the dilution is a pure loss for existing shareholders. I have spent the last 27 years observing markets, and I have learned that the most important question is not "what is the price going to do" but "who is on the other side of this trade." For Capital B's existing shareholders, the other side is the warrant holders, who have the option to buy shares at prices below what the market might eventually pay. The warrant holders have a clear incentive to exercise if the stock rises above the exercise prices. Existing shareholders are effectively shorting volatility against the warrant holders. They benefit if the stock stays stable, but they lose if it rises significantly because of the dilution. There is also the question of what happens if the warrants are exercised. Does the company use the proceeds to buy more Bitcoin, or does it use them for other purposes? The company has stated its intention to increase per-share BTC holdings, but the disclosed math shows that warrant exercise alone would reduce per-share BTC by 24.1 percent unless the proceeds are used to buy a significant amount of additional Bitcoin. To offset the dilution from warrant exercise, the company would need to buy roughly 1,000 Bitcoin at current prices, which is far more than the €21 million raised in this placement. This is the hidden information that most investors will miss. The company can claim it is increasing Bitcoin exposure, and the headline numbers support that claim. But the per-share metric tells a different story. The dilution embedded in the warrant structure means that even successful execution of the financing plan results in reduced Bitcoin exposure for existing shareholders unless Bitcoin's price appreciation more than compensates for the dilution. The takeaway here is not that Capital B is a bad company or that Bitcoin Treasury Companies are inherently flawed. The takeaway is that the risk-reward profile is significantly worse than the narrative suggests, and that investors need to dig deeper into the capital structure before allocating capital. The warrant structure, the authorized capital, and the undisclosed dilution instruments all point to a company that is willing to use shareholder dilution as a tool to grow its Bitcoin holdings. In a bull market, this can work. In a bear market, it can be catastrophic. The signals to watch are clear. First, watch the warrant exercise patterns. If more than 50 percent of warrants are exercised, expect further per-share dilution. Second, watch Bitcoin's price. If it breaks below key support levels, the company's ability to raise additional capital will be impaired. Third, watch for follow-on financing announcements. If the company announces a raise larger than €50 million, the dilution risk becomes even more severe. Fourth, watch regulatory developments. If European regulators start scrutinizing Bitcoin Treasury Companies, the entire sector could face headwinds. I have been through multiple market cycles, and I have learned that the most valuable skill is not predicting the future but identifying structural weaknesses before they become obvious. Capital B's warrant structure is a structural weakness. It is not fatal by itself, but it combines with the company's market position, governance structure, and reliance on Bitcoin appreciation to create a risk profile that deserves serious caution. And for the contrarian angle, I would note that the market's focus on "increasing Bitcoin holdings" as a positive metric may be misplaced. The question is not how much Bitcoin the company holds, but how much Bitcoin each shareholder owns. A company that raises €1 billion, buys Bitcoin, and dilutes shareholders by 50 percent is not creating value for existing shareholders unless Bitcoin doubles from the purchase price. The narrative of "Bitcoin Treasury Company" has become a marketing tool that obscures the underlying dilution economics. I have also observed that the Bitcoin Treasury Company model has a natural scaling limit. As more companies adopt this model, the marginal utility of another company holding Bitcoin declines. The market already has MicroStrategy as the dominant player. Following at a smaller scale with less favorable financing terms is a difficult position. Capital B may succeed, but the odds are stacked against it. In conclusion, the Capital B raise is a case study in how narrative can obscure structural risk. The headline numbers look positive, but the underlying capital structure tells a different story. The 24.1 percent potential dilution from warrant exercise, the undisclosed dilution instruments, the authorized capital overhang, and the reliance on Bitcoin's continuous appreciation create a risk profile that is significantly worse than the "European company buys Bitcoin" narrative suggests. I have seen enough market cycles to know that the best time to identify structural weaknesses is during a bull market, when everything looks easy. The time to worry is not when the market crashes, but when the structural risks are being ignored because the narrative is strong. Watch the plumbing, not the price. In this case, the plumbing has a leak.